[The place of fibrinolytic and antiplatelet-aggregation agents in therapy].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011379:Prognosis; D011655:Pulmonary Embolism / Q000517:prevention & control; D013300:Streptokinase / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control
D000933:Antifibrinolytic Agents; D006493:Heparin; D013300:Streptokinase
La place des médicaments fibrinolytiques et anti-agrégants plaquettaires en thérapeutique.